Magneto Thrombectomy Solutions
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Magneto Thrombectomy Solutions - overview
Location
Or Yehuda, -, Israel
Primary Industry
Medical Devices & Equipment
About
Based in Or Yehuda, Israel, Magneto Thrombectomy Solutions operates as a medical device company focused on developing innovative thrombectomy solutions. The company was founded by its CTO, Yuval Taff. Magneto Thrombectomy Solutions raised venture funding from Peregrine Ventures. As of 2024, the company is led by its CEO, Benny Dilmoney.
Magneto develops medical devices to remove blood clots, particularly in the lungs and brain. The firm’s product line includes Magneto catheters, which are devices that use electric fields to attract and remove clots. The company offers products such as the eTrieve™ PE kit, which is tailored for treating pulmonary embolisms (PE). This device uses a large bore aspiration catheter and electric attachment technology to remove emboli with minimal interaction with the artery.
Current Investors
Peregrine Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices
Website
www.magts.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.